JPMorgan Chase & Co. reiterated their overweight rating on shares of Oxford Nanopore Technologies (LON:ONT - Free Report) in a research report sent to investors on Friday,London Stock Exchange reports.
ONT has been the subject of a number of other reports. Berenberg Bank restated a "buy" rating and issued a GBX 282 ($3.59) target price on shares of Oxford Nanopore Technologies in a research note on Tuesday, September 3rd. Deutsche Bank Aktiengesellschaft restated a "buy" rating and issued a GBX 190 ($2.42) price objective on shares of Oxford Nanopore Technologies in a research note on Wednesday, September 4th. Five research analysts have rated the stock with a buy rating, According to MarketBeat, the stock presently has an average rating of "Buy" and an average target price of GBX 235.50 ($3.00).
Read Our Latest Stock Report on Oxford Nanopore Technologies
Oxford Nanopore Technologies Stock Performance
Oxford Nanopore Technologies stock traded down GBX 5 ($0.06) during trading hours on Friday, hitting GBX 150 ($1.91). The stock had a trading volume of 2,066,350 shares, compared to its average volume of 1,928,528. The company has a 50-day moving average of GBX 143.58 and a two-hundred day moving average of GBX 126.79. The company has a quick ratio of 6.01, a current ratio of 4.45 and a debt-to-equity ratio of 8.07. Oxford Nanopore Technologies has a fifty-two week low of GBX 85 ($1.08) and a fifty-two week high of GBX 212.59 ($2.71). The company has a market cap of £1.41 billion, a PE ratio of -750.00 and a beta of 0.80.
Insider Buying and Selling at Oxford Nanopore Technologies
In other Oxford Nanopore Technologies news, insider Gurdial (Gordon) Sanghera sold 1,993,571 shares of the business's stock in a transaction dated Tuesday, October 15th. The shares were sold at an average price of GBX 142 ($1.81), for a total value of £2,830,870.82 ($3,608,043.36). Insiders have purchased 306 shares of company stock worth $44,850 over the last three months. Company insiders own 32.62% of the company's stock.
About Oxford Nanopore Technologies
(
Get Free Report)
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.
Featured Stories
Before you consider Oxford Nanopore Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oxford Nanopore Technologies wasn't on the list.
While Oxford Nanopore Technologies currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
